ea0049ep947 | Pituitary - Clinical | ECE2017
Soare Iulia Simona
, Betivoiu Minodora Andreea
, Martin Sorina Carmen
, Sirbu Anca Elena
, Barbu Carmen Gabriela
, Albu Alice Ioana
, Fica Simona
Background: Acromegaly is a rare severe disease which, untreated, leads to increased cardiovascular and respiratory morbidity and mortality. Pituitary surgery is the first-line therapy, and medical treatment (somatostatin receptor ligands SRLs, dopamine agonists DA, and GH receptor antagonists GHRAs) is indicated for persistent disease. While selected patients are treated with DA and GHRAs, SRLs remain the mainstay of acromegaly therapy.Objective: The ai...